[ad_1]
Medicine to prevent a person from becoming infected with the coronavirus and developing the disease. This is the goal of an experiment started in Great Britain, according to the guardian. Antibody therapy could provide 6 to 12 month immunity against the disease and could be given as emergency treatment to hospitalized patients and nursing home residents. In this way, the appearance of outbreaks with the participation of fragile subjects would be avoided. The drug could also be given to people who live in families where someone has contracted the virus.
“If we can show that this treatment works and can prevent people exposed to the virus from developing the disease related to Covid-19 – says Professor Catherine Houlihan, virologist at the University College London Hospitals NHS Trust (UCLH) – I would add one more element to the arsenal of weapons that is being developed to combat this terrible virus.
The studio was dubbed a storm chaser. The drug, according to the online edition of the newspaper, was developed by UCLH and AstraZeneca, the pharmaceutical company that, together with the University of Oxford, has also created one of the vaccines to be used against the coronavirus.
The aim of the study is to show that the antibody cocktail protects against Covid for a period of between six and 12 months. The subjects involved in the trial receive two doses, one after the other. If approved, it reads, the treatment would be offered to someone who has been exposed to Covid in the previous eight days. The drug could be available from March or April if it gets the go-ahead from the national regulatory body.
“To date, we have administered the drug” to 10 participating subjects (staff, students, and others) who have been exposed to the virus at home, in a healthcare setting, or in student classrooms, “Houlihan said.
